TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed May 13, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 3
- 0 vs. Q4 2023
- Portfolio value
- $206.4M
- −$39.8M (−16.2%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TNGXTango Therapeutics, Inc. | COM | 19,201,475 | $152.5M | 73.9% | −162,500−0.8% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,132,867 | $31.8M | 15.4% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 2,343,154 | $22.1M | 10.7% | 00.0% | Unchanged | History |